VIDEO: Allergan, Inc. Announces the 'BOTOX(R) Cosmetic: Express Success' Charitable Education Campaign, Committing $250,000 to the Not-For-Profit Dre

Actress and singer Vanessa Williams serves as campaign ambassador

May 15, 2009 (IRVINE, Calif.) /PRNewswire/ — In honor of working women who have helped make BOTOX® Cosmetic (Botulinum Toxin Type A) the most popular physician-administered aesthetic treatment for the last seven years , Allergan, Inc. (NYSE: AGN) has announced the "BOTOX® Cosmetic: Express Success" charitable education campaign. Spearheaded by actress and singer Vanessa Williams, the campaign will benefit the not-for-profit Dress for Success, an organization that helps disadvantaged women succeed in the workforce, through a $250,000 donation from Allergan. The donation will support the organization in its efforts to promote the economic independence of disadvantaged women by providing professional attire, a network of support and the career development tools to help women thrive in work and in life.

"Dress for Success is about more than providing business attire to women in need. Our mission is to change women's lives by enabling them to express success and confidence in their professional endeavors," said Joi Gordon, CEO of Dress for Success. "We're excited to partner with Allergan and Vanessa Williams to raise awareness of Dress for Success."

As part of the donation to Dress for Success, up to $50,000 of the total $250,000 donation will be generated through an online drive, with Allergan donating $2 to the organization on behalf of each of the first 25,000 people who visit and register on the campaign Web site, ExpressSuccessCampaign.com. When pledging support on the Web site, people also can enter to win a trip for two to New York City to have lunch with Vanessa Williams, read Vanessa's personal blog as well as get interview and workplace tips.

In addition to the donation, the "BOTOX® Cosmetic: Express Success" campaign includes a series of educational events featuring campaign ambassador, Vanessa Williams, Dress for Success CEO Joi Gordon and an aesthetic-specialty physician. The events will take place in select markets across the country where consumers will be able to support Dress for Success by donating nearly new professional attire as a cost of entry, while learning about fast and simple tips for working women, including treatment with BOTOX® Cosmetic.

"As a working woman and actress, I know how important it is to 'look the part' when interviewing for a new position or in any professional setting. It's no secret that I receive BOTOX® Cosmetic treatments, which is a quick procedure that reduces the two frown lines in between my brows that look like an '11' and give me a tired or stressed appearance," said Ms. Williams. "For me, putting my best face forward means finding ways to help other women express their own success, personally and professionally. That's why I'm so excited to be involved with the 'BOTOX® Cosmetic: Express Success' campaign benefiting Dress for Success, which has helped more than 500,000 women prepare for, find and keep the job that ultimately leads to financial independence. There is truly no better time to get involved than now, so I ask all women to join our efforts by pledging their support online, joining us at our local events and participating in our New York City launch event."

Vanessa Williams will host the "BOTOX® Cosmetic: Express Success" campaign launch event with Allergan and Dress for Success on June 30 in New York City's Union Square. The event includes a celebrity "Rack Relay Race" and clothing drive. The public is invited to join Vanessa in the race by donating nearly new professional clothing and registering to race on ExpressSuccessCampaign.com. The first 100 people to pre-register online and participate in the "Rack Relay Race" will receive a certificate for a physician consultation and, if appropriate, a complimentary BOTOX® Cosmetic treatment from a licensed and trained aesthetic-specialty physician. The winning "Rack Relay Race" team also will win an opportunity to have lunch with Vanessa Williams in New York City.

Additional information about the launch and local events is available on the campaign Web site which also features an inspiring animated video featuring Vanessa Williams and three Dress for Success graduates directed by Dex Deboree, a highly acclaimed Grammy®-award nominee.

"We are pleased to launch the 'BOTOX® Cosmetic: Express Success' campaign on behalf of the women who have helped make BOTOX® Cosmetic the most popular physician administered treatment over the past seven years," said Robert Grant, president of Allergan Medical, a division of Allergan, Inc. "During this time, Allergan has developed many programs to educate women about the product, especially the importance of seeing a licensed and trained physician. Through this campaign, Allergan also will be realizing the important philanthropic goal of helping disadvantaged women around the country fulfill their professional potential and express their success. It's a first of its kind campaign for BOTOX® Cosmetic and we are proud to be partnering with both Dress for Success and Vanessa Williams on this important mission."

For more information about BOTOX® Cosmetic and the "BOTOX® Cosmetic: Express Success" campaign, please visit www.ExpressSuccessCampaign.com.
About BOTOX® Cosmetic

BOTOX® Cosmetic (Botulinum Toxin Type A) was approved by the U.S. Food and Drug Administration (FDA) in 2002 for the temporary improvement in the appearance of moderate to severe glabellar lines (the vertical "frown lines" between the eyebrows) in adult women and men ages 18 to 65. The glabellar lines, which often look like the number "11," can have a negative effect on one's overall facial appearance by creating a sad, angry, or tired impression.

BOTOX® Cosmetic has been ranked as the number one physician-administered, aesthetic injectable treatment2 and 11.8 million treatment sessions with BOTOX® Cosmetic have been recorded in the United States alone.3 High patient satisfaction rates following treatment with BOTOX® Cosmetic have been well established with 97 percent of patients indicating satisfaction with the product, according to a survey of approximately 1,000 patients conducted by the research arm of the American Society for Aesthetic Plastic Surgery (ASAPS).4
Important BOTOX® Cosmetic (Botulinum Toxin Type A) Information

BOTOX® Cosmetic is approved for the temporary treatment of moderate to severe frown lines between the brows in people ages 18 to 65.
Important Safety Information

BOTOX® Cosmetic injections should not be given to people who have an infection where the physician proposes to inject. They should not be given to people who are known to be sensitive to any ingredient in BOTOX® Cosmetic.

Serious heart problems and serious allergic reactions have been reported rarely. If you think you are having an allergic reaction or other reactions, such as difficulty swallowing, speaking, or breathing, call your doctor immediately. The most common side effects following injection include temporary eyelid droop and nausea. Localized pain, infection, inflammation, tenderness, swelling, redness, and/or bleeding/bruising may be associated with the injection. Patients with certain neuromuscular disorders such as ALS, myasthenia gravis, or Lambert-Eaton syndrome may be at increased risk of serious side effects.

The FDA on April 30, 2009, in its update to the early communication sent in 2008, gave the following recommendations:

* Understand that dosage strength (potency) expressed in "Units" or "U" are different among the botulinum toxin products; clinical doses expressed in units are not interchangeable from one botulinum toxin product to another.
* Be alert to and educate patients and caregivers about potential adverse events due to distant spread of botulinum toxin effects following local injections including: unexpected loss of strength or muscle weakness, hoarseness or trouble talking (dysphonia), trouble saying words clearly (dysarthria), loss of bladder control, trouble breathing, trouble swallowing, double vision, blurred vision and drooping eyelids.
* Understand that these adverse events have been reported as early as several hours and as late as several weeks after treatment.
* Advise patients to seek immediate medical attention if they develop any of these symptoms.

Please click here for BOTOX® Cosmetic full product information.
About Dress for Success

Dress for Success is an international not-for-profit organization that promotes the economic independence of disadvantaged women by providing professional attire, a network of support and the career development tools to help women thrive in work and in life. Since starting operations in 1997, Dress for Success has expanded to more than 90 cities in the U.S., Canada, Mexico, the Netherlands, New Zealand, Poland, the UK and the West Indies. To date, Dress for Success has helped more than 500,000 women work towards self-sufficiency. Visit http://www.dressforsuccess.org to learn more.
About Vanessa Williams:

Vanessa Williams has achieved success in every area of entertainment, including the worlds of music, theatre, film and television. She has sold millions of albums, earning multiple Grammy® Award nominations and countless other awards and honors. She has starred in numerous films, television and Broadway productions and has won or been nominated for the Emmy®, Golden Globe® and Screen Actors Guild® awards and has won two NAACP Image Awards for her role as the deliciously wicked Wilhelmina Slater on the hit ABC series, "Ugly Betty." Concord Records will release her 13th album, "The Real Thing" in June and she recently appeared in the box-office hit, "Hannah Montana: The Movie."
About Allergan, Inc.

Founded in 1950, Allergan, Inc., with headquarters in Irvine, California, is a multi-specialty health care company that discovers, develops and commercializes innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential – to see more clearly, move more freely, express themselves more fully. The Company employs more than 8,000 people worldwide operates state-of-the-art R&D facilities and world-class manufacturing plants. In addition to its discovery-to-development research organization, Allergan has global marketing and sales capabilities with a presence in more than 100 countries.
Forward-Looking Statements

This press release contains "forward-looking statements", including the statements by Ms. Gordon, Ms. Williams and Mr. Grant and other statements regarding the "BOTOX® Cosmetic: Express Success" charitable education campaign. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Allergan's expectations and projections. Risks and uncertainties include, among other things, general industry and market conditions; technological advances and patents attained by competitors; challenges inherent in the research and development and regulatory processes; challenges related to product marketing, such as the unpredictability of market acceptance for new products and/or the acceptance of new indications for such products; inconsistency of treatment results among patients and the potential for product failures; unknown risks associated with the investigational devices that are the subject of clinical trials; potential difficulties in manufacturing new products; general economic conditions; and governmental laws and regulations affecting domestic and foreign operations. Allergan expressly disclaims any intent or obligation to update these forward-looking statements except as required to do so by law.

Additional information concerning these and other risk factors can be found in press releases issued by Allergan, as well as Allergan's public periodic filings with the Securities and Exchange Commission, including the discussion under the heading "Risk Factors" in Allergan's 2008 Form 10-K and Allergan's Form 10-Q for the quarter ended March 31, 2009. Copies of Allergan's press releases and additional information about Allergan is available on the World Wide Web at www.allergan.com or you can contact the Allergan Investor Relations Department by calling (714) 246-4636.

© 2009 Allergan, Inc. Irvine, CA 92612. ® marks owned by Allergan, Inc.
Grammy® is a registered trademark of The Recording Academy
Screen Actors Guild® is a registered trademark of the Screen Actors Guild
Emmy® is a registered trademark of the Academy of Television Arts & Sciences and the National Academy of Television Arts & Sciences (ATAS/NATAS)
Golden Globe® is a registered trademark of the Hollywood Foreign Press Association
APC53TZ09

###

_______________________
1American Society of Plastic Surgeons; "Top Five Minimally-Invasive Cosmetic Procedures" 2002, 2003, 2004, 2005, 2006, 2007, 2008.
2American Society of Plastic Surgeons; "Top Five Minimally-Invasive Cosmetic Procedures" 2002, 2003, 2004, 2005, 2006, 2007, 2008.
3Allergan data on file; Global Regulatory Affairs
4Aesthetic Surgery Education & Research Foundation press release "First-of-its-kind Survey Finds That BOTOX® Cosmetic has Gone Mainstream" Released 04/28/06



Allergan Contacts
Caroline Van Hove (714) 246-5134 (media)
Kellie Reagan (714) 246-2278 (media)
Dress for Success Contact
Erin Moran (646) 233-4954 (media)